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Isoproterenol-induced Vasovagal Syncope: A
Detailed Hemodynamic Analysis
Win K. Shen. Phillip A. Low. Thomas M. Munger. Marshall S. Stanton. Michael
J. Osborn. Douglas L. Packer. Stephen C. Hammill. Mayo Clinic, Rochester, MN
Intervention HR EDV PF PR
T;lt(10 min) 8.9 ± 10.3 -14.7 ± 4.3' -9.3± 79 53.8± 12.1'
Iso/Supine** 407 ± 153' 7.9 ± 6.2' 23.8± 8.6' -272 ± 8.5'
IsolTilt** 67.8 ± lOS' ~4.8 ± 5.2 23.3 ± 142' -22.6 ± 8.2'
Syncope 4.6± 228 71.6 ± 20.4' 63.3 ± 22.4' -54.7 ± 11.5'
LW indices were measured in consecutive 2 rnin segrnents throughout the
study.
Results: Eight pts had positive tests (syncope was induced by HUT; Group
1, G1) and 7 pts in negative tests (Group 2, G2). Data were shown below
[SSP, systolic blood pressure; mean in HR and SBP; Suo supine; A and A%,
differenctJs between values at 2 min of HUT and maximally changed values
IMx) during HUT; LlH, ratio of Land H components].
Before syncope, LVVs in G1 gradually and more profoundly declined than
those in G2. The values of H significantly increased from supine to 2 min
prior to syncope in G1. Also, the values of H at 2 min prior to syncope in G1
was significantly higher than those at Mx in G2 (14 ± 7 vs. 7 ± 4 ms, p <
0.05).
Conclusions: Simultaneous measurements of LW and HRV during HUT
are useful for evaluating pathophysiology of neurally mediated syncope. Pre-
ceding decrease of LW can trigger exaggerated parasympathetic activity in
patients with vasovagal syncope.
Baroreflex failure (BRF) due to local causes was reported as a syndrome of
labile hypertension, exaggerated response to cold pressor test (CPT) and
elevated plasma catecholamines. We hypothesized that the pattern of au-
tonomic abnormalities is different in the idiopathic type of BR dysfunction
(BRD). Twenty four subjects (13 M: 11 F; age 62 ± 16 yrs.) with tilt-induced
orthostatic hypotension (OH) were tested for: Valsalva. CPT, baroreflex sen-
sitivity (heart rate response to acute BP alteration using Phenylephrine [PEl
and amylnitrite inhalation [ANII. BRD was diagnosed by blocked Valsalva, ab-
normal PE and/or AN. Two groups were defined by the results of BR and tilt;
19 with BRD (OH-BRD) and 5 with normal BR (OH-NBR). They were com-
pared to results in 31 control subjects (19 M: 12 F; age 40 ± 15 yrs.) who
had normal tilt and normal BR (N-NBR). Plasma Norepinephrine INE) was
determined in supine and tilt positions. Results:
*p < 0.05. ** Iso = 3 meg/min
We interpret these findings as HUT induces a decrease in preload (EDV),
an increase in sympathetic-mediated vascular tone (PR), and an insignifi-
cant change in cardiomotor tone as indirectly reflected by HR and PF. Iso
blunts HUT-induced changes in EDV & PR but significantly increases PF. Dur-
ing HUT + Iso-provoked vasovagal response. there is a further decrease in
PR but a significant increase in EDV & PF. These observations suggest: 11)
Iso-mediated increase in cardiomotor tone and decrease in vasomotor tone
contribute to the induction of vasovagal syncope; (2) Contrary to the conven-
tional belief, a significant decrease in preload may not occur during HUT +
Iso-induced vasovagal response.
Usefulness of head-up tilt (HUTI ± Isoproterenol (Iso) testing in the provo-
cation of a vasovagal response has been well recognized. Due to the in-
vasive and intermittent nature of cardiovascular monitoring, understanding
of the mechanisms underlying the HUT ± Iso-mediated reactions has been
limited. By using impedance cardiography, volume clamp photoplethysmog-
raphy. and internally developed computer technology, we have been able to
examine noninvasively, on-line, beat-to-beat, hemodynamic parameters in-
cluding: heart rate (HRl. blood pressure, cardiac output, stroke volume, end
diastolic volume (EDV). peak flow (PF), and peripheral resistance (PR) during
HUT ± Iso testing. In this study, hemodynamic changes were examined in
10 consecutive patients (mean age 53 ± 21, range 22-84 yrs; male/female
= 6/41 during an induction of a vasovagal response by HUT ± Iso testing.
These changes are shown below.
Percent of Change from Baseline (supine) Parameters
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Percutaneous Cardiopulmonary Bypass Support
(PCPS) for the Treatment of Acute Fulminant
Myocarditis Unresponsive to Maximum Medical
Therapy
Abiomed Ventricular Assist Device as a Bridge to
Transplantation
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Present study tested the hypothesis that the great decline of left ventric-
ular volume ILVV) during Head-up tilt IHUT) triggers ventricular mechanore-
ceptor activation and subsequently increases parasympathetic activation as-
sociated with hypotension-bradycardia. We measured temporal changes of
frequency domain heart rate variability indices (HRV) and LW using M mode
echocardiogarphy during HUT (800 up to 40 min) in 15 patients (pts, 50 ± 23
years) with syncope of undetermined etiology. HRV consisted of low (L. 0.04
Hzl, high (H, 0.15-0.40 Hz) and total (T, 0.01-1.00 Hz) components. For LW
analysis, EDV. ESV and EF were calculated using Teichholtzformula. HRV and
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The Abiomed BVS 5000 ventricular assist device IVADI is simple to implant
and monitor and allows for u'ni- or bi-ventricular support. Previous trials have
demonstrated the efficacy of this device for short-term post-cardiotomy sup-
port. We report our experience using this VAD for circulatory support as a
bridge to transplantation.
Twenty-six patients underwent Abiomed placement as a bridge to trans-
plantation between January 1988 and July 1994 in three institutions. Indica-
tions included end-stage cardiomyopathy (18). post cardiotomy failure (6).
and acute rejection (2). Average age among recipients was 44 years (7-60).
and average duration of support was 6 days (1-13 daysl. Twenty-one patients
received biventricular while 5 had univentricular (4 left. 1 right) support. One
patient was bridged to a long-term device prior to transplantation and a sec-
ond patient with a long-term support device underwent Abiomed placement
for right heart failure. Complications were seen in 9 patients and included
reversible (4) and irreversible (1) neurological deficits and bleeding requiring
re-exploration (4). No infectious complications were seen. Following trans-
plantation, 16 patients (62%) were discharged from the hospital and 10 pa-
tients (38%) succumbed to multisystem organ failure.
The Abiomed VAD is suitable circulatory support as a bridge to a long-term
device or cardiac transplantation and is particularly useful for individuals who
are too small for alternative devices or who are too unstable for long-term
device placement.
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Some acute myocarditis is refractory to conventional therapies including
IASP and is rapidly culminating in death without extracorporeal circulatory
support In order to study possible effectiveness of PCPS against this sub-
group, acute fulminant myocarditis (AFM). we have reviewed our experi-
ences and have examined the clinical outcome following PCPS treatment.
Since 1986, we have applied emergency PCPS to 10 AFM pts (mean 38
years) with rapidly progressive cardiac dysfunction and sustained wide GRS
VTNf with hemodynamic collapse. The average interval from the onset of
the very early signs of AFM (common cold like symptoms) to the induction
of PCPS was 5.2 days. IASP was routinely applied before. during and after
PCPS. Nafamostat mesilate (1 mg/kg/hr,iv) was also administered in combi-
nation with Heparin (ACT> 200 sec) as prophylaxis for bleeding complica-
tions. Histological examinations obtained from 12 endomyocardial biopsies
and 2 autopsies revealed various inflamatory changes in myocardium in all
of the 8 pts examined. Although the courses and degree of recovery varied
among the pts, PCPS could be eventually weaned in all pts after a mean of
167 hours (ranging 37-302 hours). After the removal of PCPS, 2 old pts (> 70
years) expired within 1 week due to sepsis and 1 pt expired 4 months later
due to multiple organ failure. Seventy percent of pts (7 of 10) survived, 6
pts recovered to show normal cardiac function (mean EF = 0.62) and 1 pt
showed DCM like chronic heart failure (EF = 0.321 Although nonsustained
VT was observed in 3 of 7 survivors. they have been experiencing an event
free follow-up period (mean 4.8 years).
Conclusion: Hemodynamic support by PCPS in the acute phase of AFM
was shown to be an effective treatment and the long-term outcome of the
survivors was shown to be excellent in the majority of the cases.
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